Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome

Blood

Volumn 92, Issue 9, 1998, Pages 3105-3114

  Barker, Edward ^b   Mackewicz, Carl E ^b   Reyes Terán, Gustavo ^b   Sato, Akihiko ^b   Stranford, Sharon A ^b   Fujimura, Sue H ^b   Christopherson, Cindy ^b   Chang, Sheng Yung ^b   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SURVIVAL TIME; VIROGENESIS; VIRUS LOAD; VIRUS REPLICATION;

EID: 0032211145     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3105     Document Type: Article

References (46)

1. Rutherford GW, Lifson AR, Hessol NA: Course of HIV-1 infection in a cohort of homosexual and bisexual men: An 11 year follow up study. Br Med J 301:1183, 1990
2. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD: Long-term HIV-1 infection without immunologic progression. AIDS 8:1123, 1994
3. Munoz A, Kirby AJ, He YD, Margolick JB, Visscher BR, Rinaldo CR, Kaslow RA, Phair JP: Long-term survivors with HIV-1 infection: Incubation period and longitudinal patterns of CD4+ lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 8:496, 1995
4. Barker E, Barnett SW, Stamatatos L, Levy JA: The human immunodeficiency viruses, in Levy JA (ed): The Retroviridae, vol 4. New York, NY, Plenum, 1995, p 1
5. Easterbrook PJ: Non-progression in HIV infection. AIDS 8:1179, 1994
6. Levy JA: HIV pathogenesis and long-term survival. AIDS 7:1401, 1993
7. Cao Y, Qin L, Zhang L, Safrit J, Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 332:201, 1995
8. Pantaleo G, Menzo S, Vaccarazza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, Margolick JB, Buchbinder S, Giorgi JV, Fauci AS: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332:209, 1995
9. Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, Sheppard HW: The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 3:338, 1997
10. Karlsson A, Parsmyr K, Sandstrom E, Fenyo EM, Albert J: MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J Clin Microbiol 32:364, 1994
11. Koot M, Vos AHV, Keet RPM, de Goede REY, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, Tersmette M: HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6:49, 1992
12. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185:621, 1997
13. Pan L-Z, Werner A, Levy JA: Detection of plasma viremia in HIV-infected individuals at all clinical stages. J Clin Microbiol 31:283, 1993
14. Landay A, Ohlsson-Wilhelm B, Giorgi JV: Application of flow cytometry to the study of HIV infection. AIDS 4:479, 1990
15. Levy JA, Shimabukuro J: Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions, and from clinically healthy individuals. J Infect Dis 152:734, 1985
16. Mackewicz CE, Onega HW, Levy JA: CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 87:1462, 1991
17. Mulder J, McKinney N, Christopherson C, Sninksy J, Greenfield L, Kwok S: Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 32:292, 1994
18. Levy JA, Rowe WP: Lack of requirement of murine leukemia virus for early steps in infection of mouse embryo cells by murine sarcoma virus. Virology 45:844, 1971
19. Mackewicz CE, Blackbourn DJ, Levy JA: CD8+ cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 92:2308, 1995
20. Hoffman AD, Banapour B, Levy JA: Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326, 1985
21. Castro B A, Weiss CD, Wiviott LD, Levy JA: Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. J Clin Microbiol 26:2371, 1988
22. Mackewicz CE, Barker E, Greco G, Reyes-Teran G, Levy JA: Do β-chemokines have clinical relevance in HIV infection? J Clin Invest 100:921, 1997
23. McDougal JS, Cort SP, Kennedy MS, Cabridilla CD, Feorino PM, Francis DP, Hicks D, Kalyanaraman VS, Martin LS: Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). J Immunol Meth 76:171, 1985
24. Tateno M, Levy JA: MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV). Virology 167:299, 1988
25. Martinson JJ, Chapman NH, Rees DC, Liu Y-T, Clegg JB: Global distribution of the CCR5 gene 32-basepair deletion. Nature Genetics 16:100, 1997
26. Cheng-Mayer C, Homsy JM, Evans LA, Levy JA: Identification of HIV subtypes with distinct patterns of sensitivity to serum neutralization. Proc Natl Acad Sci USA 85:2815, 1988
27. Walker CM, Erikson AL, Hsueh FC, Levy JA: Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J Virol 65:5921, 1991
28. Mackewicz CE, Barker E, Levy JA: Role of β-chemokines in suppressing HIV replication. Science 274:1393, 1996
29. Centers for Disease Control: Update: Acquired immunodeficiency syndrome-United States, 1992. J Am Med Assoc 270:930, 1993
30. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2:1240, 1996
31. Walker CM, Moody DJ, Stiles DP, Levy JA: CD8 + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563, 1986
32. Barker E, Mackewicz CE, Levy JA: Effects of TH1 and TH2 cytokines on CD8 + cell response against human immunodeficiency virus: Implications for long-term survival. Proc Natl Acad Sci USA 92:11135, 1995
33. Landay AL, Mackewicz C, Levy JA: An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol 69:106, 1993
34. Keet IPM, Krol A, Klein MR, Veugelers P, de Wit J, Roos M, Koot M, Goudsmit J, Miedema F, Coutinho RA: Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J Infect Dis 169:1236, 1994
35. Itescu S, Rose S, Dwyer E, Winchester R: Certain HLA-DR5 and DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci USA 91:11472, 1994
36. Steel CM, Beatson D, Cuthbert RJG, Morrison H, Ludlam CA, Peutherer JF, Simmonds P, Jones M: HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1:1185, 1988
37. Westby M, Manca F, Dalgleish AG: The role of host immune responses in determining the outcome of HIV infection. Immunol Today 17:120, 1996
38. Rinaldo C, Huang XL, Fan ZF, Ding M, Beltz L, Logar A, Panicali D, Mazzara G, Liebmann J, Cottrill M, Gupta P: High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 69:5838, 1995
39. Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W, Jr: Patterns of T lymphocyte changes with human immunodeficiency virus infection: From seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 2:63, 1989
40. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R: Elevated levels of CD38 + CD8 + T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up. J Acquir Immune Defic Syndr 6:904, 1993
41. Ho HN, Hultin LE, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoce D, Chou CC, O'Rourke S, Taylor JMG, Giorgi JV: Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 150:3070. 1993
42. Vanham G, Kestens L, Penne G, Giolav C, Gigase P, Colebunders R, Vandenbruaene M, Goeman J, van der Groen G, Ceuppens JL: Subset markers of CD8+ cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol 11:345, 1991
43. Vicenzi E, Bagnarelli P, Santagostino E, Ghezzi S, Alfano M, Sinnons MS, Fabio G, Turchetto L, Moretti G, Lazzarin A, Mantovani A, Mannucci PM, Clementi M, Gringeri A, Poli G: Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood 89:191, 1997
44. Piatak M Jr, Saag S, Yang LC, Kappes JC, Luk K-C, Hahn BH, Shaw GM, Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749, 1993
45. Montefiori DC, Pantaleo G, Fink LM, Zhou JT, Zhou JY, Bilska M, Miralles GD, Fauci AS: Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect Dis 173:60, 1996
46. Arendrup M, Nielsen C, Hansen J-ES, Pedersen C, Mathiesen L, Nielsen JO: Autologous HIV-1 neutralizing antibodies: Emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J Acquir Immune Defic Syndr 5:303, 1992